A trial in a New York hospital is testing the heartburn medication Pepcid as a treatment for COVID-19, according to a report in Science. Pepcid, a generic drug marketed by Merck MRK, +0.66% and Johnson & Johnson JNJ, +1.29% , is being tested on 187 COVID-19 patients in critical status at Northwell Health in the New York City area.